On-Demand Webinars

Seismic Change: Preparing for the Practical Realities of the IRA and EU JCA

On-Demand Webinar Apr 26, 2024

Charting a Path to FDA Advisory Committee Success in a Sea of Change

On-Demand Webinar Mar 28, 2024

Time is Ticking: Are You Ready for the EU HTA Regulation?

On-Demand Webinar Jan 11, 2024

Shifting Costs, Shifting Opportunity: Understanding the Impact of IRA changes to Part D

On-Demand Webinar Dec 13, 2023

Earlier or Faster? The Impact of the IRA on Oncology Drug Development

On-Demand Webinar Oct 26, 2023

Commercialization as ‘Plan A’: Innovator Biotechs Must Define and Own Their Commercial Strategy, Beginning Early

On-Demand Webinar Oct 26, 2023

Early Interception in Cancer: How Can the Current Medical and Industry Paradigm of Managing Advanced Cancer Be Turned on Its Head?

On-Demand Webinar Oct 25, 2023

Meet the ‘Patient of the Future’: How Evolving Healthcare Trends are Changing Expectations and Behaviors

On-Demand Webinar Oct 3, 2023

Helping Make Tumors Hot: Have Cancer Vaccines Come in from the Cold?

On-Demand Webinar Jun 29, 2023

Discussions on Disruptive Psychiatry

On-Demand Webinar Jun 27, 2023

The Growing Pipeline of First-Time Commercializers and the Challenges of New Enterprise Commercialization

Now that we are back from what is arguably the most important week in the life sciences calendar, we want to know what the sentiment is for fundraising in 2023 and will it get better in 2024.

On-Demand Webinar May 9, 2023

On the Backside of the Hype Cycle: Cancer Cell Therapy Companies Grappling with Lofty Expectations and Challenging Market Conditions

On-Demand Webinar Apr 26, 2023

The Current “Not” State of the Art in Immuno-Oncology Combinations

On-Demand Webinar Mar 3, 2023

Finding Optimism and Advocacy Through Adversity

On-Demand Webinar Feb 28, 2023

The New Burden of Proof: Platform, Concept and Relevance

On-Demand Webinar Feb 17, 2023

Inflation Reduction Act and Potential Impacts to BioPharma

The IRA represents a landmark policy change in the United States. Shifting financial responsibilities and benefit structures will change product strategies, risk-sharing models, and behaviors. In this webinar we examine potential direct and indirect impacts to stakeholders including pharmaceutical and biotech manufacturers, payers, physicians, and patients. Watch now.

On-Demand Webinar Feb 10, 2023